Functional Analysis of α-Synuclein in Ectopic Neuronal Cell Cycle Re-Entry
α-突触核蛋白在异位神经元细胞周期再进入中的功能分析
基本信息
- 批准号:9181324
- 负责人:
- 金额:$ 3.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-01-01 至 2017-12-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAlzheimer&aposs disease modelAmino AcidsAmyloid beta-ProteinAnti-HIV AgentsAttenuatedBrainCell Culture TechniquesCell CycleCell Cycle ProteinsCell Cycle RegulationCognitive deficitsCytokinesisDNA Sequence AlterationDNA biosynthesisDiseaseDisease ProgressionEventFrequenciesFunctional disorderFutureHistopathologyHumanIn VitroInclusion BodiesInvestigationKnockout MiceLewy BodiesLinkMass Spectrum AnalysisMitoticModelingMusMutateMutationNerve DegenerationNeurodegenerative DisordersNeuronal DysfunctionNeuronsParkinson DiseasePathogenesisPathologyPatientsPhosphorylationPoint MutationPost-Translational Protein ProcessingProteinsRecombinantsReportingRoleS PhaseSeveritiesSubfamily lentivirinaeSystemTestingTherapeuticTissue SampleToxic effectTransgenic MiceWestern Blottingabeta oligomeralpha synucleinbrain tissuecandidate markercombatcytotoxicitydrug discoveryearly onsetexperimental studyextracellularfollow-upfrontal lobehistological stainsin vivoinduced pluripotent stem cellinhibitor/antagonistmonomermutantnerve stem cellneuron lossneurotoxicoverexpressionpresynapticpreventprotein expressionpublic health relevancerelating to nervous systemsynucleinopathytau Proteinstau dysfunctiontau mutationtau phosphorylationtheoriestherapeutic developmenttoolvirtual
项目摘要
DESCRIPTION (provided by applicant): α-Synuclein (α-Syn) is a 140-amino acid presynaptic protein whose normal function remains poorly understood (Bendor et al., 2013). Histological staining of α-Syn indicate that misfolded fibrils of the protein are the primary component of Lewy
body (LB) inclusions found in the brains of patients afflicted with Parkinson's Disease (PD) and other neurodegenerative orders including Alzheimer's disease (AD). In fact, it is widely accepted that the aggregation of α-Syn is responsible for a subset of these neurodegenerative disorders appropriately referred to as Synucleinopathies (Spillantini and Goedert, 2000). However, the mechanism(s) of α-Syn toxicity, and its precise role in AD, remain unknown. Despite laudable efforts to combat AD and PD, none of the attempts made to date have been successful at halting or preventing disease progression. Therefore, a greater understanding of α-Syn toxicity is essential to identify alternative therapeutic approaches. Duplication or triplication of the gee that encodes α-Syn or point mutations in the protein (A53T, A30P, E46K) is fully penetrant for early-onset PD. The prevailing theory is that mutation or accumulation of α-Syn becomes toxic through the formation of oligomers and fibrils. Extracellular application of preformed α-Syn oligomers or fibrils induces neuronal dysfunction and subsequent degeneration, with the oligomers demonstrating the greatest cytotoxicity. One potential mechanism for α-Syn toxicity involves an underappreciated event in PD, ectopic cell cycle re-entry (CCR) (Wang et al., 2009), where quiescent neurons re-enter the cell cycle and eventually die. However, the functional role of α-Syn in neuronal CCR remains virtually unknown. Thus, using various models of AD and PD, the hypothesis that α-Syn modulates CCR through a conserved tau-dependent mechanism will be tested. The results from these experiments, and the tools that are generated, will aid drug discovery efforts and future investigations on the role of α-Syn in neurodegenerative diseases.
描述(由申请人提供):α-突触核蛋白(α-Syn)是一种140个氨基酸的突触前蛋白,其正常功能仍然知之甚少(Bendor等人,2013年)。α-Syn的组织学染色表明,蛋白质的错误折叠纤维是Lewy的主要成分
在患有帕金森病(PD)和包括阿尔茨海默病(AD)在内的其他神经退行性疾病的患者的大脑中发现的LB包涵体。事实上,人们普遍认为α-Syn的聚集是这些神经退行性疾病的一个子集(适当地称为突触核蛋白病)的原因(Spillantini和Goedert,2000)。然而,α-Syn毒性的机制及其在AD中的确切作用仍然未知。尽管在对抗AD和PD方面做出了值得称赞的努力,但迄今为止所做的任何尝试都没有成功阻止或预防疾病进展。因此,更好地了解α-Syn毒性对于确定替代治疗方法至关重要。 编码α-Syn的gee的重复或三重或蛋白质中的点突变(A53 T、A30 P、E46 K)对于早发性PD是完全渗透性的。流行的理论是α-Syn的突变或积累通过形成寡聚体和原纤维而变得有毒。预先形成的α-Syn寡聚体或原纤维的细胞外应用诱导神经元功能障碍和随后的变性,其中寡聚体表现出最大的细胞毒性。 α-Syn毒性的一种潜在机制涉及PD中未被充分认识的事件,异位细胞周期再进入(CCR)(Wang等人,2009),其中静止的神经元重新进入细胞周期并最终死亡。然而,α-Syn在神经元CCR中的功能作用几乎仍然未知。因此,使用AD和PD的各种模型,将检验α-Syn通过保守的tau依赖性机制调节CCR的假设。 这些实验的结果和产生的工具将有助于药物发现工作和未来对α-Syn在神经退行性疾病中作用的研究。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tau: The Center of a Signaling Nexus in Alzheimer's Disease.
- DOI:10.3389/fnins.2016.00031
- 发表时间:2016
- 期刊:
- 影响因子:4.3
- 作者:Khan SS;Bloom GS
- 通讯作者:Bloom GS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shahzad Shahbaz Khan其他文献
Shahzad Shahbaz Khan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shahzad Shahbaz Khan', 18)}}的其他基金
Functional Analysis of α-Synuclein in Ectopic Neuronal Cell Cycle Re-Entry
α-突触核蛋白在异位神经元细胞周期再进入中的功能分析
- 批准号:
9053898 - 财政年份:2016
- 资助金额:
$ 3.28万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 3.28万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 3.28万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 3.28万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 3.28万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 3.28万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 3.28万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 3.28万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 3.28万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 3.28万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 3.28万 - 项目类别:














{{item.name}}会员




